TOKYO-- Eisai will launch its treatment for Alzheimer's disease in China this July with a major health care provider there under plans announced Wednesday, entering the third market after Japan and the U.S.
Health Care
Eisai to offer Alzheimer's drug in China from July
Online service with JD.com will provide support for receiving treatment
Co-developed by Eisai, lecanemab is the first drug shown to be effective in slowing the progression of symptoms of Alzheimer's disease. (Eisai)
Read Next
Latest on Health Care
